1. Date & Time | Opening Date | Time | |
From | To | From | To |
2022-01-13 | 2022-01-14 | 09:10 | 16:20 |
2. Place | 1:1 meetings / conference calls | ||
3. Participant | Domestic institutional investors | ||
4. Purpose | To improve investors' understanding of the company | ||
5. Method | Non-Deal Roadshow | ||
6. Major Contents | Business Overview and Q&A | ||
7. Sponsor | Hana Financial Investment | ||
8. Opening Decision Date | 2022-01-10 | ||
9. Person in charge of IR | Department(Name) | Investor Relations (Michael Cho) | |
Contact Number(Fax Number) | 031-8092-3280(031-8092-3284) | ||
10. IR Material Publication | Publication Date | 2022-01-13 | |
Publication Place |
Presentation content and slides will be available through our website on 2022-01-13 date - KRX's KIND(Korea Investor's Network for Disclosure) System (http://kind.krx.co.kr) - www.bridgebiorx.com ▶Investor ▶Presentations & Events |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Bridge Biotherapeutics Inc. published this content on 10 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 January 2022 07:47:06 UTC.